Outcomes of Tracheobronchial Stents in Patients With Malignant Airway Disease Anthony Lemaire, MD, William R. Burfeind, MD, Eric Toloza, MD, PhD, Scott Balderson, PA-C, Rebecca P. Petersen, MD, David H. Harpole, MD, Thomas A. D’Amico, MD The Annals of Thoracic Surgery Volume 80, Issue 2, Pages 434-438 (August 2005) DOI: 10.1016/j.athoracsur.2005.02.071 Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival analysis of patients after tracheobronchial stent placement (median survival, 3.4 months; 1-year survival, n = 21). The Annals of Thoracic Surgery 2005 80, 434-438DOI: (10.1016/j.athoracsur.2005.02.071) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier plot for survival after stenting. Patients who received adjuvant radiation therapy (XRT) had significant survival advantage for the first year compared with patients who did not receive post-stent treatment (p < 0.03, Cox proportional hazard). The Annals of Thoracic Surgery 2005 80, 434-438DOI: (10.1016/j.athoracsur.2005.02.071) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions